Study shows pros and cons of triple therapy in COPD

The combination cuts exacerbations but is associated with an increased risk of pneumonia

Triple therapy reduces exacerbations and improves lung function and quality of life more than dual and monotherapy therapy in advanced COPD, but it does not improve survival and is associated with an increased risk of pneumonia, a study shows.